about
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.Access to CD4 Testing for Rural HIV Patients: Findings from a Cohort Study in ZimbabweUsing BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.Estimating the Burden of Leptospirosis among Febrile Subjects Aged below 20 Years in Kampong Cham Communities, Cambodia, 2007-2009.Tracing defaulters in HIV prevention of mother-to-child transmission programmes through community health workers: results from a rural setting in Zimbabwe.The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014Brief Report: Decentralizing ART Supply for Stable HIV Patients to Community-Based Distribution Centers: Program Outcomes From an Urban Context in Kinshasa, DRC.Relationship Between Time to Initiation of Antiretroviral Therapy and Treatment Outcomes: A Cohort Analysis of ART Eligible Adolescents in Zimbabwe.Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study.Loss to follow-up among children and adolescents growing up with HIV infection: age really mattersCyclone Nargis in Myanmar: lessons for public health preparedness for cyclones.Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare.Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment Center.Assessment of the MSF triage system, separating patients into different wards pending Ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014.Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014.The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from EthiopiaNeglected tropical diseases and the sustainable development goals: an urgent call for action from the front lineLongitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study
P50
Q33764787-43939DBB-17F8-4CAE-93FE-AEA01F519445Q35665866-99C682D2-E9AC-4722-AA66-5AD9D362A26BQ35752283-F4728A99-D376-4F79-B3F4-F2A6F2C09FB6Q35978998-5D88ED16-BAA6-479C-AA66-DB26330041C0Q36157709-36E2BDE2-6BFF-4CAD-92FD-F01F61585395Q36250219-B0B39C7E-2137-4433-A0B7-39932D479FDCQ37639072-CE58CD8D-E372-4992-84D0-20919429C84FQ37659143-29AED767-C9EB-4CA2-A045-7F6ECC39E642Q38848932-E27A51B6-B2D3-470C-B9B3-452CED97E7DBQ38849652-C6C229CF-E652-4E39-89DA-EF1B6128A875Q39108565-F7D033B4-D8FD-4D07-9250-82A608161E30Q39563998-19C15A2C-0B7A-4237-B8D6-FCA0B2B011B2Q39640496-C3B31973-8F7E-451B-BD1F-B28AE3F0AD42Q40124388-70C901B5-1DF3-4DA4-8B04-F03ABFB5CD0AQ40186573-A931B99B-E91D-4ECF-B97A-5E81D8EE342AQ41919175-F98D9BB7-C4D1-41E7-9738-DECBD6E092AEQ47735229-08597789-1C65-4B57-86CB-E010F59BB83CQ53693255-97A9BE53-C5EA-4947-84B8-747819302F5DQ57922379-5CF944C6-CDE8-4F1F-A086-218C54B91973Q62486011-D706A434-5309-4F59-A660-A9C444D1383BQ90589848-1362F719-66DC-4F42-B770-BEB7E57FB444
P50
description
researcher ORCID: 0000-0003-2686-3149
@en
wetenschapper
@nl
name
Florian Vogt
@ast
Florian Vogt
@en
Florian Vogt
@es
Florian Vogt
@nl
Florian Vogt
@sl
type
label
Florian Vogt
@ast
Florian Vogt
@en
Florian Vogt
@es
Florian Vogt
@nl
Florian Vogt
@sl
prefLabel
Florian Vogt
@ast
Florian Vogt
@en
Florian Vogt
@es
Florian Vogt
@nl
Florian Vogt
@sl
P106
P21
P214
167146937725813831584
P31
P496
0000-0003-2686-3149
P734
P735
P7859
viaf-167146937725813831584